MOLECULAR TARGETS FOR THE THERAPEUTIC MANIPULATION OF APOPTOSIS IN BLADDER CANCER
- 1 March 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 165 (3), 946-954
- https://doi.org/10.1016/s0022-5347(05)66582-2
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- A novel tumor-specific gene therapy for bladder cancerMedical Hypotheses, 1999
- Telomerase activity in patients with transitional cell carcinomaCancer, 1999
- Chromosomal aberrations associated with invasion in papillary superficial bladder cancerThe Journal of Pathology, 1998
- Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transferOncogene, 1998
- A Novel Gene Delivery System Using Urothelial Tissue Engineered Neo-OrgansJournal of Urology, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancerInternational Journal of Cancer, 1996
- Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patientsMutation Research, 1994
- Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective studyBritish Journal of Cancer, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990